机译:评估一步核酸扩增(OSNA)分析作为乳腺癌术前淋巴结转移检测的术中程序的适用性
Department of Pathology, Singapore General Hospital, Singapore, Singapore;
Department of Pathology, Singapore General Hospital, Singapore, Singapore;
Department of Pathology, Singapore General Hospital, Singapore, Singapore;
Department of General Surgery, Singapore General Hospital, Singapore, Singapore;
Department of Surgical Oncology, National Cancer Center, Singapore, Singapore;
Department of Surgical Oncology, National Cancer Center, Singapore, Singapore;
Department of Surgical Oncology, National Cancer Center, Singapore, Singapore;
Department of Surgical Oncology, National Cancer Center, Singapore, Singapore;
Department of General Surgery, Singapore General Hospital, Singapore, Singapore;
Department of General Surgery, Singapore General Hospital, Singapore, Singapore;
Department of Pathology, Singapore General Hospital, Singapore, Singapore;
Department of Pathology, Singapore General Hospital, 20 College Road, Academia, Level 7, Diagnostics Tower, Singapore 169856, Singapore;
机译:一步法核酸扩增(OSNA)术中评估乳腺癌前哨淋巴结状况:原发性肿瘤和淋巴结转移中CK19蛋白表达和CK19 mRNA水平的比较研究
机译:一步法核酸扩增(OSNA)术中评估乳腺癌前哨淋巴结状况:CK19蛋白表达和CK19 mRNA在原发性肿瘤和淋巴结转移中的比较研究
机译:一步核酸扩增法术前预测乳腺癌前哨淋巴结转移的非前哨淋巴结转移
机译:3D-CT淋巴结在乳腺癌中哨淋巴结转移评估中的可行性和功效
机译:在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
机译:一步法核酸扩增测定法(OSNA)在乳腺癌治疗中进行前哨淋巴结转移的术中诊断
机译:一步法核酸扩增(OSNA)全节点测定在乳腺癌前哨淋巴结(SLN)分析中的优势